Elevated glutamate and NMDA disrupt production of the second messenger cyclic GMP in the early postnatal mouse cortex.
The second messenger cyclic guanosine monophosphate (cGMP) plays many roles during nervous system development. Consequently, cGMP production shows complex patterns of regulation throughout early development. Elevated glutamate levels are known to increase cGMP levels in the mature nervous system. A number of clinical conditions including ischemia and perinatal asphyxia can result in elevated glutamate levels in the developing brain. To investigate the effects of elevated glutamate levels on cGMP in the developing cortex we exposed mouse brain slices to glutamate or N-methyl D-aspartate (NMDA). We find that at early postnatal stages when the endogenous production of cGMP is high, glutamate or NMDA exposure results in a significant lowering of the overall production of cGMP in the cortex, unlike the situation in the mature brain. However, this response pattern is complex with regional and cell-type specific exceptions to the overall lowered cGMP production. These data emphasize that the response of the developing brain to physiological disturbances can be different from that of the mature brain, and must be considered in the context of the developmental events occurring at the time of disturbance.
Currie
Douglas A
DA
Department of Biology, University of Washington, Seattle, Washington 98195, USA. dcurrie@usm.maine.edu
Corlew
Rebekah
R
de Vente
Jan
J
Moody
William J
WJ
D000818:Animals; D000831:Animals, Newborn; D002540:Cerebral Cortex / Q000187:drug effects* / Q000378:metabolism; D006152:Cyclic GMP / Q000378:metabolism*; D018698:Glutamic Acid / Q000494:pharmacology*; D007150:Immunohistochemistry; D051379:Mice; D016202:N-Methylaspartate / Q000494:pharmacology*; D009924:Organ Culture Techniques
D018698:Glutamic Acid; D016202:N-Methylaspartate; D006152:Cyclic GMP